A paper authored by members of an American Society of Clinical Oncology Task Force illuminates the importance of enabling patients to receive trial-related testing and care near their homes, rather than requiring patients to travel long distances to reach major research institutions.
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care.
